Chest Pain During Hemodialysis: Evaluation and Management
Patients experiencing acute unremitting chest pain during dialysis should be immediately transferred by EMS to an acute care setting for evaluation of acute coronary syndrome (ACS). 1
Immediate Management Algorithm
Step 1: Recognize the Emergency
When chest pain occurs during dialysis, assume cardiac ischemia until proven otherwise. Dialysis patients have exceptionally poor outcomes with ACS—approximately 75% mortality at 2 years 2—making rapid recognition and transfer critical for survival.
Step 2: Transfer Protocol
- Stop dialysis immediately if chest pain is unremitting
- Activate EMS transfer to an emergency department or acute care facility 1
- Do not attempt to complete the dialysis session
- Transfer with continuous monitoring
Step 3: Emergency Department Evaluation
Once in the acute care setting, evaluate using the standard triad:
- ECG findings - Look specifically for ST-segment elevation
- Cardiac biomarkers - Troponin levels (though interpretation is complex in dialysis patients)
- Clinical symptoms - Character, radiation, associated symptoms
Critical caveat: Dialysis patients presenting with chest pain have a 40.2% rate of cumulative myocardial infarction, heart failure, or death at 30 days 3. This extraordinarily high risk mandates aggressive evaluation even when initial findings seem reassuring.
Treatment Approach
For ST-Elevation MI
Emergent percutaneous coronary intervention (PCI) is the preferred treatment over thrombolytic therapy due to increased hemorrhagic risk in dialysis patients 2. If PCI is unavailable, thrombolytic therapy should still be considered as the mortality benefit likely outweighs bleeding risk.
For All ACS Presentations
Treat dialysis patients identically to the general population with these therapies 2:
- Anti-platelet agents (aspirin, clopidogrel)
- Beta-blockers
- ACE inhibitors
- Glycoprotein IIb/IIIa inhibitors (abciximab, tirofiban) as adjunctive therapy
- Lipid-lowering agents
Important exception: Avoid low molecular weight heparin due to altered clearance in kidney failure; use unfractionated heparin instead 2.
Stress Testing Considerations
If ACS is ruled out and ischemia evaluation is needed, perform stress imaging rather than standard stress testing 1. Dialysis patients have lower rates of stress testing as renal dysfunction worsens 3, but this represents a care gap rather than best practice.
Timing of Next Dialysis Session
Individualize the timing of dialysis in the first 48 hours after ACS based on:
- Volume status (pulmonary edema risk)
- Electrolyte disturbances (particularly hyperkalemia)
- Bleeding potential from anticoagulation
- Hemodynamic stability
Adjust dialysis prescriptions to minimize hypotension risk during this vulnerable period 2. Coordinate closely between nephrology and cardiology teams.
Common Pitfalls to Avoid
Dismissing chest pain as "just dialysis-related": While chest pain occurs in 1.9-13% of dialysis sessions 4, assuming benign causes can be fatal given the 40% adverse event rate 3
Delaying transfer: The guideline specifically uses "unremitting" chest pain as the trigger 1, but given the poor outcomes, err on the side of transfer for any concerning chest pain
Undertreating ACS: Historical data show dialysis patients receive inadequate post-MI treatment 2. Be aggressive with evidence-based therapies
Forgetting drug adjustments: Remember that renal clearance affects multiple cardiac medications beyond just low molecular weight heparin
Alternative Diagnoses to Consider
While cardiac ischemia is the priority, other causes of intradialytic chest pain include:
- Volume overload with pulmonary edema (resolves with ultrafiltration)
- Pericardial effusion (requires echocardiography) 1
- Hypotension-related ischemia (most common intradialytic complication at 26-30% of sessions) 4
However, these alternative diagnoses should only be considered after transfer to acute care and cardiac evaluation, not as reasons to delay transfer.